FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

38911011000001107: Sevodyne 15micrograms/hour transdermal patches (Aspire Pharma Ltd) 4 patch (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-Sep 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1583721000001117 Sevodyne 15micrograms/hour transdermal patches (Aspire Pharma Ltd) 4 patch en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1583741000001110 Sevodyne 15micrograms/hour transdermal patches (Aspire Pharma Ltd) 4 patch (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sevodyne 15micrograms/hour transdermal patches (Aspire Pharma Ltd) 4 patch Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Sevodyne 15micrograms/hour transdermal patches (Aspire Pharma Ltd) 4 patch Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Sevodyne 15micrograms/hour transdermal patches (Aspire Pharma Ltd) 4 patch Is a Buprenorphine 15micrograms/hour transdermal patches 4 patch true Inferred relationship Existential restriction modifier
Sevodyne 15micrograms/hour transdermal patches (Aspire Pharma Ltd) 4 patch Has AMP Sevodyne 15micrograms/hour transdermal patches (Aspire Pharma Ltd) true Inferred relationship Existential restriction modifier
Sevodyne 15micrograms/hour transdermal patches (Aspire Pharma Ltd) 4 patch Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Sevodyne 15micrograms/hour transdermal patches (Aspire Pharma Ltd) 4 patch Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Sevodyne 15micrograms/hour transdermal patches (Aspire Pharma Ltd) 4 patch VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Sevodyne 15micrograms/hour transdermal patches (Aspire Pharma Ltd) 4 patch Has specific active ingredient Buprenorphine true Inferred relationship Existential restriction modifier
Sevodyne 15micrograms/hour transdermal patches (Aspire Pharma Ltd) 4 patch VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Sevodyne 15micrograms/hour transdermal patches (Aspire Pharma Ltd) 4 patch Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 3 (CD No Register) true Inferred relationship Existential restriction modifier
Sevodyne 15micrograms/hour transdermal patches (Aspire Pharma Ltd) 4 patch Has dispensed dose form Prolonged-release transdermal patch true Inferred relationship Existential restriction modifier
Sevodyne 15micrograms/hour transdermal patches (Aspire Pharma Ltd) 4 patch Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start